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Abstract
Background: Midkine is a small heparin binding growth factor expressed in numerous tissues during development.
The unique midkine gene in mammals has two paralogs in zebrafish: midkine-a (mdka) and midkine-b (mdkb). In the
zebrafish retina, during both larval development and adult photoreceptor regeneration, mdka is expressed in retinal
stem and progenitor cells and functions as a molecular component of the retina’s stem cell niche. In this study,
loss-of-function and conditional overexpression were used to investigate the function of Mdka in the retina of the
embryonic zebrafish.
Results: The results show that during early retinal development Mdka functions to regulate cell cycle kinetics.
Following targeted knockdown of Mdka synthesis, retinal progenitors cycle more slowly, and this results in
microphthalmia, a diminished rate of cell cycle exit and a temporal delay of cell cycle exit and neuronal
differentiation. In contrast, Mdka overexpression results in acceleration of the cell cycle and retinal overgrowth.
Mdka gain-of-function, however, does not temporally advance cell cycle exit. Experiments to identify a potential
Mdka signaling pathway show that Mdka functions upstream of the HLH regulatory protein, Id2a. Gene expression
analysis shows Mdka regulates id2a expression, and co-injection of Mdka morpholinos and id2a mRNA rescues the
Mdka loss-of-function phenotype.
Conclusions: These data show that in zebrafish, Mdka resides in a shared Id2a pathway to regulate cell cycle
kinetics in retinal progenitors. This is the first study to demonstrate the function of Midkine during retinal
development and adds Midkine to the list of growth factors that transcriptionally regulate Id proteins.
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Background
Neurogenesis relies on the coordinated interplay of in-
trinsic and extrinsic mechanisms that determine the
spatial and temporal patterns of proliferation, initiate
cell cycle exit, fix cell identities, and govern differenti-
ation. The vertebrate retina is a long-standing model for
investigating the mechanisms that govern developmental
neurogenesis [1]. The retina has a limited number of cell
types arrayed in evolutionarily highly conserved spatial
patterns and functional circuits, and experimental altera-
tions of retinal development are easy to detect by simple
microscopic inspection. Cell-extrinsic signals govern
retinal development by modulating intrinsic signals that
can drive self-renewal, cell cycle exit, and differentiation.
For example, growth factors at the midline divide the
early eye field into two retinal anlagen that express
unique combinations of transcription factors [2], and
signaling centers both outside and inside the eye pattern
the optic vesicle and initiate cell cycle exit and neuronal
differentiation [1].
Midkine is a secreted heparin binding growth factor with
a molecular weight of 13 kDa that is a member of the
midkine/pleiotrophin family of growth factors [3]. Midkine
is highly conserved among vertebrates and plays an impor-
tant role in both development and disease. In mammals,
midkine is highly expressed during embryogenesis, and
down-regulated at birth. In the mammalian central nervous
system (CNS), the expression of midkine is temporally and
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spatially regulated in a manner that suggests it functions to
govern aspects of neurogenesis [3-7], although this has not
been experimentally tested.
The unique midkine gene in mammals has two para-
logs in zebrafish: midkine-a (mdka) and midkine-b
(mdkb). In zebrafish, the two sub-functionalized genes
have non-overlapping patterns of expression and inde-
pendent biological functions [8-11]. In the embryonic
and larval retina of zebrafish, mdka is expressed in ret-
inal progenitors, but immediately down-regulated in
these cells as they exit the cell cycle. During photorecep-
tor regeneration in the adult retina, both mdka and
mdkb are up-regulated in Müller glia as these cells re-
enter the cell cycle and adopt the features of retinal stem
cells [10].
Here we establish that Mdka controls the cell cycle
kinetics of retinal progenitors in the embryonic retina of
zebrafish and functions upstream of the intrinsic HLH
regulatory protein, Id2a. Following targeted knockdown
of Mdka synthesis, retinal progenitors progress more
slowly through the cell cycle, and this gives rise to
microphthalmia, a diminished rate of cell cycle exit and
delay of neuronal differentiation. In contrast, Mdka
overexpression results in acceleration of the cell cycle
and a transient retinal overgrowth, but Mdka gain-
of-function does not temporally advance cell cycle exit.
Gene expression analysis shows that Mdka regulates
id2a expression, and co-injection experiments show that
id2a mRNA rescues morpholino-induced Mdka loss-
of-function. These data demonstrate that in the develop-
ing vertebrate retina the Mdka/Id2a pathway functions
to regulate cell cycle kinetics and identifies Mdka as an
extrinsic regulator of neurogenesis in the vertebrate
central nervous system.
Results
Mdka knockdown transiently blocks neuronal
differentiation
To inhibit Mdka synthesis, two non-overlapping mdka
morpholinos (MO1, MO2; Figure 1A) were used. Con-
trol morpholinos contained five mismatched nucleotides
(MM1, MM2; Figure 1A). At 48 hours post fertilization
(hpf ), embryos injected with the mdka-targeted morpho-
linos are indistinguishable from controls with respect to
body size and shape, though experimental embryos dis-
play a mild, but statistically significant decrease in eye
size (Figure 1B; uninjected (UI) vs. Mdka morpholinos,
P=0.0002; MM morpholinos vs. Mdka morpholinos,
P=0.001). Both MO1 (4 ng/embryo) and MO2 (5 ng/
embryo) produced similar retinal phenotypes, and the
specific suppression of Mdka protein synthesis was con-
firmed for MO1 (Figure 1C). All Mdka knockdown
experiments presented here were performed using MO1.
Figure 1 Mdka-targeted morpholinos inhibit Mdka synthesis
and delay neuronal differentiation. (A) Sequences of the two
morpholino oligos (MO1, MO2) and the respective mismatch (MM)
controls used in this study. (B) Representative embryos from the
control and experimental groups at 48 hours post fertilization (hpf).
(C) Western blot prepared from 48 hpf embryos. MM, embryos
injected with 5-nucleotide mismatch control morpholinos; MO,
embryos injected with MO1 Mdka- targeted morpholinos; UI,
uninjected control. Note the absence of protein in embryos injected
with the mdka-targeted morpholinos (similar results were observed
using MO2.) The upper bands are stained with antibodies against
actin and serve as loading controls. (D) (a, d, g) Sections taken
through the retinas of uninjected embryos (UI) at 48 hpf and stained
with antibody markers for ganglion cells (zn12; zn5) and amacrine
cells (HPC-1), respectively. (b, e, h) Sections of retinas of embryos
injected with 5-nucleotide mismatch morpholinos (MM1) and
immunostained as above. (c, f, i) Retinas of embryos injected with
Mdka translation-blocking morpholinos (MO1) and immunostained
as above. Note the absence of differentiation markers that label
inner retinal neurons. (E) Representative sections from uninjected (a),
control (b), and loss-of-function embryos (c) allowed to survive to 72
hpf. The absence of neuronal differentiation at 48 hpf is recovered
by 72 hpf. gcl, ganglion cell layer; inl, inner nuclear layer; L, lens; ON,
optic nerve; onl, outer nuclear layer; . Scale bar equals 50μm. MIP 3D;
Maximum intensity projection, three dimensional.
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Sections taken through the retinas revealed that at 48
hpf knockdown of Mdka results in small retinas, the
absence of lamination and few overtly differentiated
cells, which was confirmed using the antibody markers,
zn5, zn12, and HPC1, which label inner retinal neurons
(Figure 1D). Interestingly, however, the absence of
neuronal differentiation (and lamination) was transient.
Through 56 hpf, there was little neuronal differentiation
following Mdka loss-of-function, whereas, by 72 hpf,
even though western blot analysis showed that Mdka
synthesis remains inhibited (data not shown), experi-
mental retinas were largely normal with respect to the
lamination and neuronal differentiation (Figure 1E).
Mdka loss-of-function does not delay the onset of a
neurogenic program or increase cell death
The delayed neuronal differentiation resulting from
Mdka loss-of-function could result from four mechan-
isms, alone or in combination: (1) delay in the onset of
the developmental neurogenic program; (2) apoptosis of
newly post mitotic cells; (3) normal cell cycle exit but
failure to differentiate; or (4) lengthening of the cell
cycle, resulting in a temporal delay in cell cycle exit and,
consequently, an absence of neuronal differentiation. In
the vertebrate retina, the proneural gene atoh7 (previ-
ously designated ath5) is an intrinsic timer required to
initiate neurogenesis. The onset of expression of atoh7
was used to test whether or not the loss of Mdka alters
the initiation or maintenance of genetic programs
required for neuronal differentiation. In zebrafish, ex-
pression of atoh7 begins at approximately 25 hpf, within
ventral-temporal retina and then expands through the
retina as a wave spreading in a dorso-nasal direction,
marking cells that are competent to exit the cell cycle
and differentiate [12,13]. In situ hybridization analysis
showed that the timing of the onset of atoh7 expression
is not altered in experimental embryos (Figure 2A, a-i),
indicating that the absence of neuronal differentiation
following Mdka knockdown does not result from simply
delaying the onset of genetic programs that endow
neurogenic competence. Further, the initial broad
expression domain of atoh7 [13] persists following Mdka
knockdown (Figure 2A, h) whereas in control embryos
atoh7 mRNA becomes restricted to progenitors at the
retinal margin (Figure 2A b,e). The persistence of the
broad atoh7 expression domain in the experimental
retinas reflects the absence of cellular differentiation
following Mdka knockdown and the neurogenic compe-
tence these cells retain (Figure 2A, h; see below).
Cell death in the developing zebrafish retina is nor-
mally very low [14]. The DNA-binding vital dye, acridine
orange, was used to label pyknotic nuclei of dying cells
in control and experimental embryos between 24 hpf
and 60 hpf. Counts of acridine orange-labeled nuclei
showed no significant differences in the number of dying
cells in the retinas of control and experimental animals
(Figure 2B). Terminal deoxynucleotidyl transferase dUTP
nick end labeling (TUNEL) was also used to mark cells
undergoing apoptosis, and no significant differences were
observed in the number of TUNEL-positive cells in control
and experimental groups (data not shown).
Figure 2 Loss of Mdka function does not affect neurogenic
competence or increase cell death. (A) In situ hybridizations
showing atoh7 expression in the retinas of uninjected (a-c), control
(d-f) and Mdka loss-of-function embryos (g-i). Arrows in panels a, d
and g identify the initial cluster of atoh7-expressing cells in ventral
retina. MM, embryos injected with 5-nucleotide mismatch
morpholinos; MO, embryos injected with mdka-targeted
morpholinos; UI, uninjected. Scale bar equals 50μm. (B) Average
number of acridine orange-stained cells in the retinas of control and
experimental embryos showing that loss of Mdka does not increase
cell death. P >0.05 for all pairwise comparisons. n=5 to 7 embryos/
time point. Scale bar equals 50 μm.
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To test whether or not following knockdown of Mdka
cells exit the cell cycle on time but merely fail to differ-
entiate, embryos were given multiple injections of EdU
between 34 hpf and 48 hpf and sacrificed at 48 hpf.
DAPI-positive/EdU-negative (post-mitotic) cells were
then counted in representative sections from experimen-
tal and control embryos (n=10 embryos/group) and
averaged to determine the relative proportion of cells
that had exited the cell cycle at 34 hpf prior to the avail-
ability of the EdU (see [15]). This analysis showed that
relative to controls, following knockdown of Mdka, sig-
nificantly fewer cells exit the cell cycle at 34 hpf
(Table 1). This result indicates that loss of Mdka func-
tion does not delay neuronal differentiation, but, rather,
alters the timing of cell cycle exit.
Mdka loss-of-function alters cell cycle kinetics
The absence of both neuronal differentiation and the
normal timing of cell cycle exit imply that Mdka func-
tions to control cell cycle kinetics. Therefore, a variety of
approaches were used to evaluate cell proliferation and
cell cycle kinetics among the retinal progenitors. This
was investigated first by providing a brief systemic pulse
of BrdU at 48 hpf and evaluating the spatial distribution
and proportion of labeled cells immediately thereafter
(Figure 3A). In control retinas the majority of proliferat-
ing cells are within the marginal germinal zone, and the
proportion of the retina occupied by proliferating cells is
low. In embryos injected with control morpholinos,
there were extra BrdU-labeled cells in the central retina,
and we interpret this to be a consequence of a simple
developmental delay resulting from the injection proce-
dures and/or presence of the morpholinos [16]. In con-
trast to control retinas, in the absence of Mdka function,
at 48 hpf BrdU-labeled progenitors are present through-
out the retina (Figure 3B), indicating that in central
retina progenitors fail to exit the cell cycle at the appro-
priate developmental stage.
To further investigate the change of cell cycle kinetics
following loss of Mdka function, the mitotic status of
retinal progenitors was measured by counting progeni-
tors labeled with antibodies that recognize the phos-
phorylated form of histone H3 (pH3), a marker specific
for cells in the M-phase of the cell cycle (Figure 3C). In
vertebrate retinas, cells undergo mitosis at the outermost
(apical) surface of the retina, and this spatial pattern of
pH3 labeling did not differ in control and experimental
retinas. However, the proportion of pH3-positive cells in
retinas lacking Mdka was significantly reduced relative
to controls (Figure 3D).
To estimate the length of the cell cycle and the dur-
ation of the relative S-phase, we employed a cumulative
BrdU labeling method [17]. This method provides a sus-
tained systemic dose of BrdU and labels all cells passing
through the S-phase of the cell cycle. BrdU was injected
into the yolk at 2-h intervals beginning at 26 hpf, for 8-
h. At 120-min intervals, three to four embryos from
each group were removed, fixed, and the proportion of
BrdU labeled cells was determined and plotted as a func-
tion of time. A linear regression was then fitted to these
data. The slope and y-intercept of the best-fit lines were
used to estimate the total length of the cell cycle and the
relative duration of the S-phase, respectively. This ana-
lysis showed that the total length of the cell cycle was
significantly longer for retinal progenitors following
Mdka loss of function (21.50 h vs. 15.0 h; Figure 3E),
and this could be accounted for largely by an increase in
the duration of the S-phase (8.75 h vs. 4.10 h). Together,
the pulse and cumulative BrdU labeling assays suggest
that following knockdown of Mdka, retinal progenitors
cycle more slowly, fail to exit the cell cycle at the appro-
priate developmental stage, and this results in the transi-
ent delay in neuronal differentiation.
Mdka overexpression produces retinal overgrowth
Transgenic fish were generated to conditionally induce
Mdka overexpression in vivo. Three lines (kec1001L3,
kec1004L4, kec1004L6) were identified that showed
germ line transmission of the inducible mdka/egfp con-
struct (pHSP70/4:mdka:egfp). When subjected to heat
shock at 24 hpf, the Mdka-GFP fusion protein was
visible in transgenic animals within 2 h, and wild-type,
hemizygous, and homozygous offspring were easily dis-
tinguished based on GFP fluorescence intensity. Fluores-
cence imaging over time and western blot analysis using
the anti-GFP antibody (the Mdka antibody does not
recognize the fusion protein) demonstrated that the
Mdka fusion protein is stable in transgenic embryos for
at least 48 h (Figure 4A, B). Consistent with our model
that Mdka governs cell cycle kinetics, Mdka gain-
of-function in early embryos resulted in a marked retinal
overgrowth (Figure 4C). Interestingly, similar to the
Table 1 Gain of Mdka function does not advance cell
cycle exit
Average number
of cells/section at
34 hpf
EdU-negative
cells at 48 hpf
(n)
Proportion of EdU-
negative cells at
48 hpf
Untreated 156 ± 22 53 ± 10 0.34 ± 0.09
Mdka l-o-f 138 ± 19 2 ± 2 0.02 ± 0.02a
WT 147 ± 23 51 ± 38 0.34 ± 0.17
Mdka g-o-f 191 ± 32 71 ± 28 0.38 ± 0.08
For each group, half the embryos were sacrificed at 34 hpf for cell counts. The
remaining embryos were injected with EdU every 6 h starting at 34 hpf and
fixed at 48 hpf. EdU-negative cells counted at 48 hpf were those that had
exited cell cycle by 34 hpf. The proportion of EdU-negative cells was not
significantly different between the untreated, WT, and Mdka g-o-f groups. The
proportion of post-mitotic cells in the Mdka l-o-f group was significantly
smaller than in controls. g-o-f, gain-of-function; l-o-f, loss-of-function. aP <0.05.
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Figure 3 Mdka loss-of-function alters cell cycle kinetics. (A) BrdU labeled progenitors in uninjected (a) control (b) and Mdka loss-of-function
embryos (c). (B) Histograms showing the average proportion of the retinal section occupied by BrdU-labeled cells. *P <0.001. n = 9 retinas/group.
Scale bar equals 50μm. (C) Retinas of embryos at 48 hpf stained with antibodies against phosphohistone H3 (pH3) in uninjected (a), control (b),
and Mdka loss-of-function embryos (c). (D) The number of pH3-stained cells/unit area. **P <0.01. n=12 embryos/group. MM, embryos injected
with 5-pair mismatch control morpholinos; MO, embryos injected with mdka-targeted morpholinos (MO); UI, uninjected embryos. gcl, ganglion
cell layer; inl, inner nuclear layer; L, lens; ON, optic nerve; onl, outer nuclear layer. Scale bar equals 50 μm. (E) Graph of the least-squares regression
lines through data showing the proportion of BrdU-labeled progenitors as a function of time. An F-test was used to compare the control and
experimental data. **P <0.05.
Luo et al. Neural Development 2012, 7:33 Page 5 of 15
http://www.neuraldevelopment.com/content/7/1/33
results from Mdka loss-of-function, the retinal over-
growth observed in early embryos was also transient and
largely resolved by 72 hpf (Figure 4D).
Mdka levels alter the length of the G2 phase of the cell
cycle
To directly evaluate cycling progenitors following Mdka
gain-of-function, FACS DNA-content analysis was used
to quantify the proportion of cells that occupy each
phase of the cell cycle. This was performed at 30 hpf
(6 h after heat shock), when the vast majority of retinal
progenitors are still proliferating and the retina lacks post-
mitotic cells [14]. Although cells from the forebrain and
non-neuronal cells surrounding the head and eyes are
included in this assay, the FACS analysis showed that
Mdka gain-of-function results in a statistically significant
decrease in the proportion of cells in the S-phase, which
was accompanied by a significant increase in the propor-
tion of cells in G2/M. The proportion of cells in the
G1-phase was unchanged (Table 1; Figure 5A, B).
Analyzing DNA content provides only the relative pro-
portion of cells in each phase of the cell cycle. Therefore,
the percent labeled mitoses paradigm (PLM; [18]) was
used to complement the FACS analysis and directly
measure the length of the G2-phase of the cell cycle
among retinal progenitors. These experiments were
performed using embryos subjected to heat shock at 24
h, sorted by genotype and evaluated between 28 hpf and
34 hpf. Due to the nature of this experiment, we were
able also to include embryos injected with mdka
morpholinos in the PLM analysis. As anticipated, the
percentage of pH3/EdU double-labeled nuclei increased
sigmoidally with time, demonstrating that the experi-
mental treatments did not affect the ability of dividing
cells to progress from the S- to M-phase of the cell
cycle. Further, qualitative observations showed that as
progenitors progress through G2 they physically moved
from the inner retina to the apical surface, where they
become coincident with pH3-positive cells [19]. Al-
though variable, the data also showed a significant differ-
ence between the three groups at the 2.5-h time point,
where nearly 100% of the progenitors with elevated
Mdka had completed G2, compared to only approxi-
mately 10% of the progenitors in retinas lacking Mdka
(Figure 5C). The values for wild-type cells were inter-
mediate between these two. These data show directly
that Mdka levels regulate progression from S- to M-
phase of the cell cycle. The acceleration of the cell cycle
following gain of Mdka function both accounts for the
retinal overgrowth resulting from Mdka gain-of-function
(Figure 4C) and is complementary to the consequences
of Mdka loss-of-function (see above).
In an effort to explore the molecular mechanisms
through which Mdka governs cell cycle kinetics, we used
in situ hybridization to evaluate the relative expression
levels of core cell cycle components, the cyclin genes,
B1, D1, E1, and the CDK gene, p27 [20,21]. There were
no apparent differences in the relative expression levels
or tissue distribution of these genes among untreated,
loss-of-function, or gain-of-function embryos (data not
Figure 4 Conditional over-expression of Mdka. (A) Induced fluorescence in a Tg(pHSP70/4:mdka:egfp) larva at 72 hpf after heat shock
treatment at 24 hpf. (B) Western blot stained with antibodies against EGFP showing induction of the fusion protein at 72 hpf after heat shock at
24 hpf. Tg, heat shock-treated, transgenic siblings; WT, heat shock-treated, wild-type embryos. (C) Mdka gain of function results in marked retinal
overgrowth at 30 hpf, which is largely resolved by 72 hpf (D). Tg, heat shock-treated embryos from the Tg(pHSP70/4:mdka:egfp) line; WT, heat
shock-treated wild-type siblings. Scale bar equals 50 μm.
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shown), suggesting that Mdka does not modulate the
duration of the cell cycle by directly regulating the
expression of cell cycle kinases or kinase inhibitors.
Gain of Mdka function does not advance cell cycle exit
Experiments were undertaken next to determine if
elevating Mdka levels also accelerates cell cycle exit.
Clutches from hemizygous transgenic crosses were trea-
ted by heat shock at 24 hpf, sorted into wild-type and
homozygous transgenic groups, given multiple injec-
tions of EdU between 34 hpf and 48 hpf, and sacrificed
at 48 hpf. DAPI-positive/EdU-negative (post-mitotic) cells
were counted and averaged to determine the relative pro-
portion of cells that had exited the cell cycle at 34 hpf
prior to the availability the EdU (see [15]; see above). The
average number of cells/retinal section was greater
following Mdka gain-of-function, reflecting the early
retinal overgrowth. However, elevating Mdka levels did
not significantly increase the proportion of post mitotic
(EdU-negative) cells over wild-type controls at 34 hpf
(34% ± 17% vs. 38% ± 9%; Table 1), demonstrating that the
Mdka-induced acceleration of the cell cycle does not also
temporally advance cell cycle exit.
Mdka functions upstream of the HLH regulatory protein
Id2a
The observations from the Mdka gain- and loss-
of-function experiments strongly resemble data reported
recently following gain- and loss-of-function of the HLH
protein, Id2a [22]. In the early larval retina of zebrafish,
Id2a is expressed in retinal progenitors where it functions
as a non-cell autonomous regulator of cell cycle kinetics.
Figure 5 Mdka gain-of-function accelerates the cell cycle. (A) Representative raw data from FACS sorting of neural progenitors at 30 hpf.
(B) Histograms showing the average percentage of cells in the G1-, S-, and G2-/M- phases of the cell cycle. *P <0.01. n=4 independent assays
from a minimum of 5,000 cells/assay. (C) Graph showing the percent labeled mitoses for embryos between 28 hpf and 34 hpf. #*P <0.01. n=4
embryos/condition/time point. MO, embryos injected with mdka-targeted morpholinos; Tg, homozygous transgenic siblings treated with heat
shock at 24 hpf; WT, untreated wild-type embryos.
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Knockdown of Id2a lengthens the cell cycle, delays neur-
onal differentiation, and produces microphthalmia, whereas
Id2a over-expression accelerates the cell cycle, leading to
retinal overgrowth. The phenotypes associated with the
gain and loss of Id2a persist through 72 hpf [22]. Gene
expression studies were performed with embryos at 28 hpf
Figure 6 Mdka functions upstream of Id2a. (A) Wholemount in situ hybridizations showing id2a expression at 28 hpf. Embryos were
uninjected (Uninjected), injected with mismatch Mdka morpholinos (Control MO), Mdka translation-blocking morpholinos (Mdka l-o-f), or
transgenic embryos treated with heat shock at 24 hpf (Mdka g-o-f). The letter ‘e’ identifies the eye. Note that id2a expression is modulated by
Mdka levels. (B) Representative control and experimental embryos at 48 hpf. Embryos were uninjected (Control), injected with id2a mRNA (id2a),
Mdka translation-blocking morpholinos (MdkaMO), or co-injected with Mdka translation-blocking morpholinos and id2a mRNA. (C) Representative
retinal sections from embryos at 48 hpf. The conventions are as above. Sections are stained with DAPI to label nuclei and antibodies against
phosphohistone H3. (D) Graph showing the number of retinal cells in each group. (E) Graph showing the number of phosphohistone H3-positive
cells in each group. Note that the number of DAPI and phosphohistone H3-positive cells are reduced following Mdka l-o-f and cell numbers are
restored following co-injections of Mdka translation-blocking morpholinos and id2a mRNA. **P <0.05. Scale bars in panel B and C are 200 μm and
50 μm, respectively.
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to determine if there is a genetic relationship between
Mdka and Id2a. First, mdka expression was evaluated by
in situ hybridization following both the loss and gain of
Id2a function. Altering Id2a levels did not alter mdka
hybridization signal (data not shown). Second, id2a expres-
sion was evaluated by in situ hybridization following Mdka
gain- and loss-of-function. For this experiment, the color
reactions were stopped simultaneously for each group at a
point where differences in the signal intensity between
loss- and gain-of-function embryos became distinct. This
resulted in an apparent incomplete pattern of id2a expres-
sion in the control embryos (Figure 6A). However, in an
independent experiment, it was confirmed that using the
same riboprobe and developing the color reaction to a suf-
ficient degree recapitulates the expression pattern specific
for id2a (Figure 7; cf. Figure 3 in Thisse et al., 2004 [23]).
The comparative in situ hybridization analysis showed that
relative expression of id2a is markedly reduced or lost fol-
lowing Mdka knockdown, whereas, relative id2a expression
is increased following Mdka overexpression (Figure 6A).
Third, quantitative Reverse Transcriptase-PCR (qRT-PCR)
was performed on mRNA isolated from heads of embryos
at 28 hpf following Mdka gain- and loss-of-function. This
analysis showed that Mdka knockdown resulted in a 1.75-
fold decrease in the expression of id2a (MM morpholinos
vs. Mdka morpholinos, P=0.03), whereas Mdka overexpres-
sion resulted in a 5.14-fold increase in the expression of
id2a (WT-heat shock vs. Tg-heat shock, P=0.018). Collect-
ively, these data were interpreted to show that in the zebra-
fish retina Mdka functions upstream of Id2a and that
Mdka levels govern the expression of id2a. To further test
this model, Mdka morpholinos and id2a mRNA were co-
injected into embryos and proliferation and neurogenesis
in the retinas were analyzed. These experiments showed
Id2a overexpression is sufficient to restore normal retinal
development following Mdka knockdown. id2a rescues the
microphthalmia (Figure 6B), restores the number of retinal
cells to control levels (Figure 6C-E), and restores the nor-
mal timing of cellular differentiation (data not shown).
These data show that in the zebrafish retina Mdka and
Id2a function within a common signaling pathway that
regulates retinal development.
Discussion
Mdka regulates cell cycle kinetics
Precisely regulated cell proliferation is a fundamental de-
terminant of organ growth. Both intrinsic and extrinsic
signaling molecules govern the kinetics of proliferation
and the timing of re-entry into or exit from the cell cycle
[24]. Relatively few studies have directly addressed the
role of Midkine in governing cell cycle kinetics. During
fetal CNS development, Midkine is necessary to main-
tain the M-phase of neural progenitor cells [25], and
transfection of drug-sensitive cells with the midkine
gene releases the drug-induced proliferation arrest and
allows cells to progress through the S-phase [26]. More
recently, midkine was shown to promote the growth of
murine embryonic stem cells by preventing apoptosis
and inducing the G1-S phase transition [7], and an
in vitro assay showed that neurospheres from Mdka defi-
cient mice are significantly smaller than those from wild
types [27]. The earlier study from our lab showing that
mdka is expressed in retinal progenitors [10] led to the
hypothesis that in the zebrafish retina Mdka functions
to regulate aspects of neurogenesis. We used loss- and
gain-of-function approaches and assays of proliferation
and cellular differentiation to test this hypothesis. The
resulting data showed that Mdka functions in retinal
progenitors to regulate kinetics of the cell cycle. Loss of
Mdka significantly increases the duration of the cell
cycle, which is manifested by a decreased number of mi-
totic cells and microphthalmia. Complementing these
results, Mdka overexpression significantly accelerates
the cell cycle, leading to a retinal overgrowth. Further,
while both morpholino-induced knockdown and induced
overexpression of Mdka synthesis persists until at least 72
hpf, the knockdown phenotype observed at 48 hpf was
recovered by 60 hpf and the induced retinal overgrowth
is largely resolved by 72 hpf. These data suggest that
Mdka function in the embryonic retina predominates
only during a relatively brief temporal window and during
this time functions narrowly to govern cell cycle kinetics.
Numerous extrinsic molecules regulate proliferation of
vertebrate retinal progenitors, including Notch, FGF,
BMP, Wnt, and HH (reviewed in [1]). Mdka can now be
Figure 7 Expression of id2a at 28hpf. In situ hybridization of
wholemount embryos at 28 hpf recapitulates the tissue-specific
pattern of id2a expression (cf. Figure 3, Thisse et al., 2004). Scale bar
equals 100 μm L, lens.
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added to this list. Finally, midkine was identified as a
component in the core transcriptional repertoire of mi-
totic progenitors in the mammalian retina and brain [4].
In light of these data, we propose that in the vertebrate
central nervous system Midkine is a component of the
complex environment of extrinsic regulatory molecules
(for example [24]) that functions, perhaps in an autocrine
manner, to regulate developmental neurogenesis.
Mdka does not directly govern cell fate determination or
neuronal differentiation
Lineage studies show that retinal progenitor cells give
rise to neuronal and glial cell types in a characteristic
order of birth [15,28,29]. Whereas Mdka knockdown
slows the onset of neuronal differentiation, overexpres-
sion of Mdka does not advance cell cycle exit. These
data suggest that the delay in neuronal differentiation
following Mdka loss-of-function is a consequence of
slowing the cell cycle, and Mdka does not normally
function to promote neurogenesis. Similarly, Mdka gain-
of-function accelerates the cell cycle, but does not also
advance cell cycle exit and neurogenesis. The non-
correlated effects between cell cycle regulation and cell-
fate determination were also observed in the retina of
disarrayed mutant zebrafish [30]. These observations,
along with the data from our experiments, suggest that
Mdka functions, perhaps narrowly, to regulate cell cycle
kinetics without influencing cell fate specification or
cellular differentiation. This stands in contrast to other
intrinsic and extrinsic regulatory molecules, which have
been shown both to coordinate cell cycle progression
and cell fate determination [1].
Mdka functions upstream of Id2a
The striking similarity in the data regarding Mdka func-
tion and those published recently describing the func-
tion of the protein, Id2a [22], led us to investigate the
potential genetic relationship between Mdka and Id2a.
Id (inhibitor of differentiation) proteins are intrinsic
components of signaling pathways that function as posi-
tive regulators of cell cycle progression in neuronal pro-
genitors [31] and key mediators of tumor progression in
transformed cells [32,33]. Id proteins lack a basic, DNA-
binding domain, and heterodimers formed between Ids
and bHLH transcription factors cannot bind DNA or
form active dimers (see [32]). Similar to Mdka, in zebra-
fish retinal progenitors, Id2a modulates S-phase progres-
sion and/or the S- to M-phase transition [22]. Loss of
Id2a function lengthens the cell cycle, leading to micro-
phthalmia and an absence of neuronal differentiation,
whereas gain of Id2a function shortens the cell cycle,
leading to retinal overgrowth. The similarities of the
Mdka and Id2a functional studies suggested the
hypothesis that in the retina Mdka and Id2a function in
a shared development pathway.
Gene expression analysis and mRNA rescue experi-
ments showed that in the developing retina Mdka func-
tions upstream of Id2a within a common signaling
pathway. Mdka is required for sustained id2a expression,
and Mdka gain-of-function is sufficient to increase the
transcription of id2a. Id2a has previously been shown to
regulate retinoblast cell cycle kinetics, therefore, these
data suggest that Mdka functions through Id2a to gov-
ern cell cycle control in the embryonic retina. This was
confirmed by experiments showing that overexpression
of id2a was sufficient to restore cell division and
eye growth to normal levels following Mdka loss-
of-function. In the developing retina of mammals, Bmp
signaling is upstream of Id expression. In the retina,
BMPs promote differentiation of retinal progenitors, and
altering BMP4 upregulates the expression of multiple Id
proteins [34]. The current study demonstrates that
Mdka also modulates Id gene expression and suggests,
therefore, that in the mammalian retina and brain Mid-
kine may also be a component of signaling events
mediated by Id proteins.
The knockdown and overexpression experiments show
that Mdka function is transient and restricted to early
retinal development. Retinas from embryos with altered
Mdka levels recovered to resemble wild-type retinas
by 72 hpf. This is in contrast to Id2a loss- and gain-
of-function, which persists through 72 hpf. There are
several possible explanations for the transient retinal
phenotypes that result from manipulating Mdka levels.
First, homeostatic mechanisms within the retina may
compensate for perturbations of Mdka signaling in the
early in retinal development. Second, the functional re-
duction and overexpression of Mdka may be transient.
Morpholino dilution beyond 48 hpf may allow sufficient
levels of Mdka synthesis to allow neurogenesis to
resume, and the early pulse of Mdka overexpression
following heat shock at 24 hpf may not be sufficient to
maintain the cell cycle compression and retinal over-
growth through 72 hpf. Third, we speculate that the
transient effects of altering Mdka levels reflect the diver-
gent patterns of cellular expression for these two genes.
In the embryonic retina, prior to the onset of neuronal
differentiation (see [15]) both mdka and id2a are
expressed in mitotic retinal progenitors ([9]; [35]; [22]).
However, by 48 hpf, id2a is down-regulated in mitotic
cells and up-regulated in a population of post-mitotic
cells in the inner nuclear layer (Figure 8). The segrega-
tion of the cellular expression indicates that the expres-
sion of mdka and id2a are differentially regulated and,
thereby, may only transiently share a common regulatory
pathway within progenitor cells during early retinal de-
velopment. At around 48 hpf, a separate mechanism
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down-regulates the expression of id2a in retinal progeni-
tors, which potentially disconnects Mdka-id2a signaling.
This raises the possibility that Mdka/Id2a signaling func-
tions in the early retina only. When these two signaling
proteins are decoupled by differential patterns of expres-
sion, cellular differentiation may occur even in the
absence of Mdka.
Conclusions
The zebrafish genome encodes two Midkine paralogs,
mdka and mdkb [8]. The potential role for Mdka in the
retina was identified in a screen for genes in zebrafish
retina that are up-regulated following photoreceptor
death and during stem cell-based photoreceptor regener-
ation [10]. In the embryonic and larval CNS, the two
midkine paralogs are differentially regulated, and each
exhibits distinct temporal and spatial patterns of cellular
expression [8,10]. Interestingly, in the retina, the expres-
sion of both midkine paralogs is induced in the intrinsic
stem cells, Müller glia, as they re-enter the cell cycle in
preparation for regenerative neurogenesis [10]. In the
present study, we showed that in the embryonic retina
of zebrafish Mdka functions to regulate cell cycle kinet-
ics in retinal progenitors and this function is mediated
through the transcriptional regulation of id2a. These
data for the embryonic retina suggest that the Mdka/
Id2a pathway may also function during the stem cell-
based neuronal regeneration in the adult zebrafish
retina.
Methods
Reagents
Nitrocellulose membranes, mouse anti-HPC-1, anti-goat
peroxidase-conjugated secondary antibodies, propidium
iodide (PI), and bromodeoxyuridine (BrdU) were pur-
chased from Sigma (St. Louis, MO, USA). Anti-zpr1,
anti-zpr3, anti-zn12, and anti-zn5 antibodies were pur-
chased from the Zebrafish International Resource Center
(ZIRC, Eugene, OR, USA). TOPRO3, Alexa Fluor 555
goat anti-rabbit IgG antibody, Alexa Fluor 555 goat anti-
mouse IgG antibody, Alexa Fluor 488 goat anti-rabbit
IgG antibody, the MultiSite Gateway Three-Fragment
Vector Construction Kit, Click-it EdU Alexa Fluor 555
Imaging Kit, and trypsin were purchased from Invitro-
gen (Carlsbad, CA, USA). Rabbit anti-phosphohistone 3
(pH3) antibodies were purchased from Millpore (Billerica,
MA, USA). Mouse anti-BrdU antibody was purchased
from BD Biosciences (Franklin Lakes, NJ, USA).
Experimental animals
AB strain zebrafish were purchased from Aquatic Tropi-
cals Inc. (Bonita Springs, FL, USA) and housed at 28.5°C
on a 14/10-h light/dark cycle. Embryos were collected
after natural spawns, incubated at 28.5°C and staged by
hpf [36].
Morpholino oligo and mRNA injections
For loss-of-function experiments, two morpholino oligos
(Gene Tools, LLC, Cowallis, OR, USA) were used that
were targeted to non-overlapping sequences in proximity
to the translation start site of the zebrafish mdka mRNA
(NCBI Reference Sequence: 131070.2). Control morpho-
linos contained a 5-nucleotide mismatch. Morpholinos
were diluted in 1× Danieau buffer [16] at 1 mg/mL, and
embryos were injected with 2 ng to 5ng of morpholinos
at the 1- to 8-cell stage.
For the mRNA rescue injections, 80 pg of id2a mRNA
in a pCS2-id2a vector was co-injected with 5 ng of Mdka
morpholino (see [22]).
Western blot analysis
Mdka and GFP were detected in western blots using
techniques described previously [9]. Proteins were
extracted from pools of 15 to 20 embryos by lysing the
embryos in buffer with protease inhibitors (Complete
Mini, Roche, Germany). Proteins were separated in a
12% SDS-PAGE gel and transferred to a nitrocellulose
membrane. The membrane was blocked in 5% non-fat
dry milk in PBS for 2 h and incubated with rabbit anti-
Figure 8 Summary diagram. The level of Mdka synthesis
systematically alters the length of the cell cycle, as indicated by the
diameter of the cell cycle cartoons (A), and the size of the eye (B).
This corresponds also to the early expression of both mdka and id2a
in retinal progenitors (B). By 48 hpf, mdka and id2a are differentially
expressed in retinal progenitors and INL neurons, respectively, which
is most evident for cells at the retinal margin (asterisks, C).
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Mdka antibody (1:300; [9]) or rabbit anti-GFP antibody
(1:500, Abcam, Cambridge, MA, USA). Blots were rinsed
with PBS and incubated with goat horseradish peroxidase-
conjugated secondary IgG (1:5,000) for 1 h. Bound anti-
bodies were visualized using the enhanced chemilumines-
cence assay (ECL detection system, Amersham Biosciences,
Arlington Heights, IL, USA). As loading controls, blots
were stripped and incubated with anti-actin (1:1,000,
Calbiochem, Germany).
Immunohistochemistry
Embryos were fixed overnight in 4% paraformaldehyde
dissolved in 100 mM phosphate buffer, cryoprotected by
infiltration in 20% sucrose in phosphate buffer, and
frozen in Optimal Cutting Temperature (OCT) media.
Cryosections at 7 to 10 μm in thickness were mounted
on glass slides and processed for immunohistochemistry
using standard procedures. Briefly, after drying, sections
were incubated with 20% normal sheep serum in phos-
phate buffered saline and 0.5% triton X-100 (PBST),
followed by overnight incubation at 4°C with primary
antibodies. After washing with PBST, sections were incu-
bated in secondary antibodies for 1 h at room
temperature, washed extensively in PBST. Sections were
counterstained with 1:1,000 dilution of DAPI to label
nuclei and sealed with mounting media and glass
coverslips.
Systemic labeling with BrdU or EdU
Proliferating cells were labeled with either BrdU or EdU
by soaking embryos for 20 min in ice-cold 5 mM BrdU
or 1.5 mM EdU dissolved in embryo rearing solution
containing 15% DMSO. For BrdU staining, sections were
incubated in 4 N HCl and immunolabeled using a
mouse anti-BrdU antibody that was visualized with goat
anti-mouse IgG antibodies conjugated to Alexa Fluor
555 [37]. EdU was visualized using the Click-iT™ EdU
imaging kit with Alex Fluor 555 according to the manu-
facturer’s protocol.
In situ hybridization
In situ hybridization on retinal sections was performed
using digoxigenin (DIG)-labeled riboprobes, synthesized
as previously described [37]. Briefly, sections were hybri-
dized with probes overnight at 55°C. The next day, the
sections were washed and incubated with an alkaline-
phosphatase-conjugated anti-DIG antibody overnight at
4°C. After washing, riboprobes were visualized using
4-nitrobluetetrazolium/5-bromo-4-chloro-3-indolyl phos-
phate (NBT/BCIP; Roche, Indianapolis, IN, USA) solution
as the enzymatic substrate (Roche).
For whole mount in situ hybridizations, embryos were
fixed in 4% paraformaldehyde, dehydrated in methanol
and stored at -20°C for a minimum of 12 h. Embryos
were then returned to room temperature, rehydrated,
fixed again in 4% paraformaldehyde, permeabilized with
0.1 M proteinase K, fixed a third time in 4% paraformal-
dehyde, treated with acetic anhydride, and washed
in PBS with 0.1% Tween. Embryos were next washed
in pre-hybridization buffer, which was removed and
replaced with 500 μL of hybridization solution contain-
ing 200 ng of probe. Embryos were hybridized overnight
at 55°C. The next day, embryos were washed and the
digoxigenin was detected using antibodies conjugated to
alkaline-phosphatase and a colorimetric reaction with
NBT/BCIP as the enzymatic substrate. Embryos were
transferred to single concavity slides for inspection and
photomicroscopy.
Acridine orange labeling
Apoptotic nuclei were visualized by labeling live
embryos with the vital exclusion dye, acridine orange. At
24 hpf, embryos were transferred to 0.003% 1-phenyl
-2-thiourea (PTU) to block melanin synthesis. At various
ages, embryos were then dechorionated and placed in
acridine orange solution (5 μg/mL in embryo medium;
Molecular Probes, Eugene, OR, USA) for 15 min fol-
lowed by extensive washes in embryo medium. Embryos
were lightly anesthetized and viewed under a fluores-
cence dissecting scope, and acridine orange-positive cells
were counted.
Transgenic lines
The Gateway-based Tol2kit system was used to generate
transgenic fish [38]. Mdka cDNA (pCS2p-mdk1; a gift
from C. Winkler), was PCR-amplified with primers
containing an attB1 site on the forward primer and a
reverse attB2 site on the reverse primer. The sequence
of these primers is as follows: Forward: 50 GGGGACAA
GTTTGTACAAAAAAGCAGGCTGTATGCGGGGCC
TGTTTTCCACC 30; Reverse: 50 GGGGACCACTTTGT
ACAAGAAAGCTGGGTCGTTCCCTTTCCCCTTGCC
TT 30. The purified PCR products with added att sites
were used immediately in BP reactions to generate mid-
dle entry clones. Multisite recombination reactions were
performed to generate the pHSP70/4:mdka:egfp expres-
sion construct.
The expression construct and in vitro transcribed Tol2
transposase mRNA were co-injected into AB wild-type
embryos at the 1- or 2-cell stage. Embryos positive for
the gene construct were identified at 72 hpf by the
HSP70/4-driven expression of EGFP in the lens ([39]).
Positive F0 fish were outcrossed to wild-type AB fish. F1
generation carriers were identified by GFP expression
following heat shock and validated by PCR with geno-
mic DNA, using primers for the sequence encoding
the enhanced green fluorescent protein. Three lines,
kec1001L3, kec1004L4, kec1004L6, were identified and
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used to propagate stable (Tg(pHSP70/4:mdka:egfp))
lines. These lines were characterized and found to yield
approximately 50% GFP-positive progeny when mated to
wild-type AB fish, suggesting a single Tol2 insertion.
One transgenic line, Tg(pHSP70/4:mdka:egfp)kec1001L3,
was used for all of the data presented here.
Flow cytometry
Embryos were collected from pairwise, hemizygous x
hemizygous matings and treated by heat shock (37°C for
60 min) at 24 hpf. Wild-type and homozygous trans-
genic embryos were identified at 26 hpf by the absence
or presence and relative intensity of GFP. At 30 hpf, 50
heads (forebrains and eyes) from each group were isolated
and washed twice in ice-cold PBS and dissociated into
single-cell suspensions in 5 mL of ice-cold 0.25 mg/mL
trypsin solution for 10 min at room temperature. Cells
were fixed in ice-cold 70% ethanol for 30 min and stained
with propidium iodide. DNA content for the isolated cells
was analyzed on a FACScan II (Becton-Dickinson), and
histograms of DNA content were acquired by CellQuest
(BD Biosciences) and MODFIT LT (Verity Software
House, Topsham, ME, USA).
Cumulative BrdU labeling
To estimate the total length of the cell cycle and the
length of the S-phase, a cumulative BrdU labeling
approach was used [17,40]. BrdU was injected into the
yolk at 2-h intervals beginning at 26 hpf, which provides
a sustained systemic dose of BrdU and labels all cells
passing through the S-phase of the cell cycle. At 30 min
after each injection, three to four embryos from each
group were removed, dechorionated, and fixed for BrdU
immunohistochemistry. At each time point, DAPI- and
BrdU-labeled nuclei were counted in retinal sections,
and the proportion of cells labeled with BrdU was deter-
mined and plotted as a function of time. A least-squares
regression line was then fit to the data.
Percent labeled mitoses
The length of the G2-phase of the cell cycle was mea-
sured using the percentage labeled mitoses paradigm
[18]. At 24 hpf, embryos were placed in embryo solution
containing PTU (see above). At 28 hpf, embryos were
incubated in the EdU/DMSO solution for 20 min then
removed and returned to embryo solution. Ten minutes
following the EdU exposure, and at 1-h intervals, subse-
quently, four embryos from each group were removed,
dechorionated, and fixed. Whole embryos were stained
with antibodies against phosphohistone H3 (pH3), fol-
lowed by EdU labeling chemistry. Nuclei were counter-
stained with 1:1,000 dilution of TOPRO3. Retinas from
whole embryos were imaged using a Leica upright con-
focal microscope (Leica DM6000 CFS) with 25× water
immersion objective. Approximately 40 to 80 optical
sections, 1 μm in thickness, were acquired for each eye.
By surveying each optical slice every pH3-positive cell
was counted and scored for the presence/absence of
EdU.
qRT-PCR
mRNA was isolated from the forebrains and eyes of
embryos at 28 hpf following either morpholino injec-
tions (mismatch morpholinos vs. Mdka-targeted mor-
pholinos) or heat shock treatment (wild type vs. Tg
(pHSP70/4:mdka:egfp)kec1001L3 from a single clutch).
Real-time PCR was performed using Power SYBER
Green PCR Master Mix (Applied Biosystems) on the
Applied Biosystems 7900HT Real Time PCR machine.
Real-time PCR data were analyzed using the Compara-
tive Ct method [41]. Fold changes in expression are nor-
malized to tubulin levels. The following primer pairs
were used: id2a forward 50 GCATCCTCTCACTACAGA
CACC 30, id2a reverse 50 CCTGATTAACGGTAAAGTG
TCCT 30; tubulin forward 50 TGGAGCCCACTGTCAT
TGATG 30, tubulin reverse 50 CAGACAGTTTGCGAA
CCCTATCT 30.
Statistical analysis
All quantitative data are represented as means and
standard deviations. Statistical significance between
groups was determined either by a one-way ANOVA or
a Student’s t-test using GraphPad Prism software
(GraphPad Software, La Jolla, CA, USA). P values <0.05
were considered statistically significant.
Imaging
Images of sectioned retinas were captured using a Leica
TCS SP5 confocal microscope (Vernon Hills, IL, USA).
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